Cargando…
Experimental Pharmacology in Transgenic Rodent Models of Alzheimer’s Disease
This Mini Review discusses the merits and shortfalls of transgenic (tg) rodents modeling aspects of the human Alzheimer’s disease (AD) pathology and their application to evaluate experimental therapeutics. It addresses some of the differences between mouse and rat tg models for these investigations....
Autores principales: | Cuello, A. Claudio, Hall, Hélène, Do Carmo, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409318/ https://www.ncbi.nlm.nih.gov/pubmed/30886583 http://dx.doi.org/10.3389/fphar.2019.00189 |
Ejemplares similares
-
Modeling Alzheimer’s disease in transgenic rats
por: Do Carmo, Sonia, et al.
Publicado: (2013) -
Longitudinal analysis of the behavioral phenotype in a novel transgenic rat model of early stages of Alzheimer's disease
por: Galeano, Pablo, et al.
Publicado: (2014) -
Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy
por: Malcolm, Janice C., et al.
Publicado: (2019) -
The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy
por: Do Carmo, Sonia, et al.
Publicado: (2021) -
Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000)